Skip to main content

Table 3 Frequency of LGMD2A, 2I, 2D, 2 L in European countries

From: Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic

Litera-ture Population Number of patients analysed in the study Number and percentage of patients with LGMD2A Number and percentage of patients with LGMD2I Number and percentage of patients with LGMD2D Number and percentage of patients with LGMD2L
This study Czech 218 LGMD2 probands 71 (67 had two mutations, 4 one); 32.6% 9; 4.1% 6; 2.8% 3; 1.4%
[28] Italy 190 LGMD probands 59; 31.1% 14; 7.4% 16; 8.4% 4; 2.1%
[2] Italy 155 LGMD probands 44 (30 had two mutations, 14 one); 28.4% 10; 6.4% 13; 8.4% NI
[32] Italy 550 patients with LGMD, myopathy, or asymptomatic hyperCKemia 102; 18.5% 16; 2.8% 37; 6.7% NI
[33] Italy 519 patients with LGMD, myopathy, or asymptomatic hyperCKemia 94 (76 had two mutations, 18 one); 18.1% NI NI NI
[10] Italy 530 patients with muscular dytrophy 141 (104 had two mutations and 37 one); 26.6% NI NI NI
[34] Italy 214 probands with muscular dystrophy or myopathy NI 13 (9 had two mutations, 4 one); 6.1% NI NI
[35] Germany 98 probands with LGMD2 and 102 probands with asymptomatic or minimally symptomatic hyperCKemia NI 7; 3.5% NI NI
[29] Denmark 99 LGMD2 patients 12; 12.1% 38; 38.4% NI NI
[4] Dutch 67 LGMD probands 14; 20.9% 5; 7.5% NI NI
[30] Dutch 68 LGMD probands NI NI NI 11; 16.2%
  1. NI: no information.